Ayşegül A. Şahin
#133,540
Most Influential Person Now
Ayşegül A. Şahin's AcademicInfluence.com Rankings
Ayşegül A. Şahinbiology Degrees
Biology
#8973
World Rank
#12122
Historical Rank
Molecular Biology
#1179
World Rank
#1205
Historical Rank
Biochemistry
#1336
World Rank
#1457
Historical Rank
Download Badge
Biology
Why Is Ayşegül A. Şahin Influential?
(Suggest an Edit or Addition)Ayşegül A. Şahin's Published Works
Number of citations in a given year to any of this author's works
Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author
Published Works
- PTEN activation contributes to tumor inhibition by trastuzumab, and loss of PTEN predicts trastuzumab resistance in patients. (2004) (1821)
- Tumour amplified kinase STK15/BTAK induces centrosome amplification, aneuploidy and transformation (1998) (1322)
- Significantly higher pathologic complete remission rate after neoadjuvant therapy with trastuzumab, paclitaxel, and epirubicin chemotherapy: results of a randomized trial in human epidermal growth factor receptor 2-positive operable breast cancer. (2005) (1123)
- An integrative genomic and proteomic analysis of PIK3CA, PTEN, and AKT mutations in breast cancer. (2008) (993)
- Microenvironment-induced PTEN loss by exosomal microRNA primes brain metastasis outgrowth (2015) (898)
- Characterization of a naturally occurring breast cancer subset enriched in epithelial-to-mesenchymal transition and stem cell characteristics. (2009) (829)
- ERK promotes tumorigenesis by inhibiting FOXO3a via MDM2-mediated degradation (2008) (653)
- IKKβ Suppression of TSC1 Links Inflammation and Tumor Angiogenesis via the mTOR Pathway (2007) (636)
- Glycosylation and stabilization of programmed death ligand-1 suppresses T-cell activity (2016) (583)
- AKT-independent signaling downstream of oncogenic PIK3CA mutations in human cancer. (2009) (510)
- Combating trastuzumab resistance by targeting SRC, a common node downstream of multiple resistance pathways (2011) (502)
- Deubiquitination and Stabilization of PD-L1 by CSN5. (2016) (453)
- Down-regulation of caspase 3 in breast cancer: a possible mechanism for chemoresistance (2002) (427)
- High risk of recurrence for patients with breast cancer who have human epidermal growth factor receptor 2-positive, node-negative tumors 1 cm or smaller. (2009) (426)
- Weekly paclitaxel improves pathologic complete remission in operable breast cancer when compared with paclitaxel once every 3 weeks. (2005) (400)
- Outcome after pathologic complete eradication of cytologically proven breast cancer axillary node metastases following primary chemotherapy. (2005) (369)
- Cyclooxygenase-2 expression in human breast cancers and adjacent ductal carcinoma in situ. (2002) (366)
- Incidence and impact of documented eradication of breast cancer axillary lymph node metastases before surgery in patients treated with neoadjuvant chemotherapy. (1999) (348)
- The 2019 World Health Organization classification of tumours of the breast (2020) (330)
- Phyllodes tumours of the breast: a consensus review (2016) (305)
- Eradication of Triple-Negative Breast Cancer Cells by Targeting Glycosylated PD-L1. (2018) (300)
- Breast conservation after neoadjuvant chemotherapy: the MD Anderson cancer center experience. (2004) (295)
- Benign breast diseases: classification, diagnosis, and management. (2006) (292)
- Proteomics of human breast ductal carcinoma in situ. (2002) (289)
- PTEN, PIK3CA, p-AKT, and p-p70S6K status: association with trastuzumab response and survival in patients with HER2-positive metastatic breast cancer. (2010) (287)
- Sentinel lymph node biopsy is accurate after neoadjuvant chemotherapy for breast cancer. (2000) (284)
- Role for Intraoperative Margin Assessment in Patients Undergoing Breast-Conserving Surgery (2007) (262)
- Postmastectomy radiation improves local-regional control and survival for selected patients with locally advanced breast cancer treated with neoadjuvant chemotherapy and mastectomy. (2004) (259)
- Triple-negative breast cancer has worse overall survival and cause-specific survival than non-triple-negative breast cancer (2016) (251)
- Altered expression of retinoblastoma protein and known prognostic variables in locally advanced bladder cancer. (1992) (246)
- Accuracy of Physical Examination, Ultrasonography, and Mammography in Predicting Residual Pathologic Tumor Size in Patients Treated With Neoadjuvant Chemotherapy (2006) (244)
- CCR7 and CXCR4 as Novel Biomarkers Predicting Axillary Lymph Node Metastasis in T1 Breast Cancer (2005) (238)
- Ganglioside GD2 identifies breast cancer stem cells and promotes tumorigenesis. (2012) (227)
- Postmastectomy radiation improves the outcome of patients with locally advanced breast cancer who achieve a pathologic complete response to neoadjuvant chemotherapy. (2007) (227)
- A naturally occurring MTA1 variant sequesters oestrogen receptor-α in the cytoplasm (2002) (222)
- PI3K Pathway Mutations and PTEN Levels in Primary and Metastatic Breast Cancer (2011) (222)
- Expression of blood-group antigen A--a favorable prognostic factor in non-small-cell lung cancer. (1991) (221)
- p21-activated Kinase-1 Signaling Mediates Cyclin D1 Expression in Mammary Epithelial and Cancer Cells* (2004) (219)
- Breast carcinoma in pregnant women (2003) (217)
- HER-2/neu gene amplification compared with HER-2/neu protein overexpression and interobserver reproducibility in invasive breast carcinoma. (2000) (211)
- Phase I/II study of trastuzumab in combination with everolimus (RAD001) in patients with HER2-overexpressing metastatic breast cancer who progressed on trastuzumab-based therapy. (2011) (206)
- Oncogenic LncRNA downregulates cancer cell antigen presentation and intrinsic tumor suppression (2019) (204)
- Dynein light chain 1, a p21-activated kinase 1-interacting substrate, promotes cancerous phenotypes. (2004) (199)
- 14-3-3zeta Cooperates with ErbB2 to promote ductal carcinoma in situ progression to invasive breast cancer by inducing epithelial-mesenchymal transition. (2009) (194)
- Prognostic Significance of Tissue Transglutaminase in Drug Resistant and Metastatic Breast Cancer (2004) (193)
- Expression of chemokine receptors predicts the site of metastatic relapse in patients with axillary node positive primary breast cancer. (2006) (187)
- Ki‐67 immunostaining in node‐negative stage I/II breast carcinoma. Significant correlation with prognosis (1991) (181)
- Molecular Cloning and Characterization of PELP1, a Novel Human Coregulator of Estrogen Receptor α (2001) (180)
- Prognostic Role of a Multigene Reverse Transcriptase-PCR Assay in Patients with Node-Negative Breast Cancer Not Receiving Adjuvant Systemic Therapy (2005) (176)
- In vivo expression of the novel CXC chemokine BRAK in normal and cancerous human tissue. (2000) (175)
- EGFR Signaling Enhances Aerobic Glycolysis in Triple-Negative Breast Cancer Cells to Promote Tumor Growth and Immune Escape. (2016) (173)
- CXCL-12/stromal cell-derived factor-1alpha transactivates HER2-neu in breast cancer cells by a novel pathway involving Src kinase activation. (2005) (169)
- Comparative allelotype of in situ and invasive human breast cancer: high frequency of microsatellite instability in lobular breast carcinomas. (1995) (162)
- American College of Surgeons Oncology Group (ACOSOG) Z0011: Impact on Surgeon Practice Patterns (2012) (162)
- Expression profile of tyrosine kinases in breast cancer. (2002) (155)
- Correlation between CpG methylation profiles and hormone receptor status in breast cancers (2007) (155)
- Combined use of clinical and pathologic staging variables to define outcomes for breast cancer patients treated with neoadjuvant therapy. (2008) (152)
- Breast conservation after neoadjuvant chemotherapy (2005) (149)
- Expression of growth factor and chemokine receptors: new insights in the biology of inflammatory breast cancer. (2007) (148)
- Chemotherapy‐Induced Apoptosis and Bcl‐2 Levels Correlate with Breast Cancer Response to Chemotherapy (2003) (144)
- 14-3-3ζ turns TGF-β's function from tumor suppressor to metastasis promoter in breast cancer by contextual changes of Smad partners from p53 to Gli2. (2015) (142)
- Lobular Carcinoma In Situ Diagnosed By Core Needle Biopsy: When Should It Be Excised? (2003) (141)
- Breast cancer molecular subtypes: from TNBC to QNBC. (2016) (137)
- Transcriptomic changes in human breast cancer progression as determined by serial analysis of gene expression (2004) (136)
- Plasmacytoid transitional cell carcinoma. Report of a case with initial presentation mimicking multiple myeloma. (1991) (136)
- Gene expression signature of estrogen receptor α status in breast cancer (2005) (135)
- Alternative splicing disrupts a nuclear localization signal in spleen tyrosine kinase that is required for invasion suppression in breast cancer. (2003) (134)
- MDA-7/IL-24 is a unique cytokine--tumor suppressor in the IL-10 family. (2004) (134)
- Hypermethylation leads to silencing of the SYK gene in human breast cancer. (2001) (131)
- Down‐regulated melanoma differentiation associated gene (mda‐7) expression in human melanomas (2001) (129)
- Integrative Analysis of Cyclin Protein Levels Identifies Cyclin B1 as a Classifier and Predictor of Outcomes in Breast Cancer (2009) (129)
- Colitis associated with docetaxel-based chemotherapy in patients with metastatic breast cancer (2000) (128)
- Intraoperative margin assessment reduces reexcision rates in patients with ductal carcinoma in situ treated with breast-conserving surgery. (2003) (128)
- Validation of a novel staging system for disease-specific survival in patients with breast cancer treated with neoadjuvant chemotherapy. (2011) (127)
- Identification and Evaluation of Axillary Sentinel Lymph Nodes in Patients With Breast Carcinoma Treated With Neoadjuvant Chemotherapy (2000) (127)
- Tissue transglutaminase-induced alterations in extracellular matrix inhibit tumor invasion (2005) (126)
- Accuracy of core needle biopsy diagnosis in assessing papillary breast lesions: histologic predictors of malignancy (2004) (126)
- Immunohistochemical analysis of P-glycoprotein expression correlated with chemotherapy resistance in locally advanced breast cancer. (1990) (123)
- Deletion map of chromosome 16q in ductal carcinoma in situ of the breast: refining a putative tumor suppressor gene region. (1996) (122)
- Multidisciplinary Considerations in the Implementation of the Findings from the American College of Surgeons Oncology Group (ACOSOG) Z0011 Study: A Practice-Changing Trial (2011) (122)
- Locoregional treatment outcomes after multimodality management of inflammatory breast cancer. (2008) (121)
- Functional implications of altered subcellular localization of PELP1 in breast cancer cells. (2005) (121)
- LIM kinase 1 increases tumor metastasis of human breast cancer cells via regulation of the urokinase‐type plasminogen activator system (2006) (120)
- Trends for inflammatory breast cancer: is survival improving? (2007) (120)
- Prognostic significance of phosphorylated P38 mitogen‐activated protein kinase and HER‐2 expression in lymph node‐positive breast carcinoma (2004) (118)
- Predictors of locoregional recurrence in patients with locally advanced breast cancer treated with neoadjuvant chemotherapy, mastectomy, and radiotherapy. (2005) (118)
- Locoregional recurrence risk for patients with T1,2 breast cancer with 1-3 positive lymph nodes treated with mastectomy and systemic treatment. (2014) (117)
- A naturally occurring MTA1 variant sequesters oestrogen receptor-alpha in the cytoplasm. (2002) (117)
- From Mice to Humans (2004) (115)
- Atypical ductal hyperplasia diagnosis by directional vacuum-assisted stereotactic biopsy of breast microcalcifications. Considerations for surgical excision. (2003) (112)
- Phase II trial of AKT inhibitor MK-2206 in patients with advanced breast cancer who have tumors with PIK3CA or AKT mutations, and/or PTEN loss/PTEN mutation (2019) (111)
- Supplemental Table 1 (2010) (111)
- A Molecular Portrait of High-Grade Ductal Carcinoma In Situ. (2015) (111)
- p21-Activated Kinase 1 Regulates Microtubule Dynamics by Phosphorylating Tubulin Cofactor B (2005) (105)
- Improving local control with breast‐conserving therapy (2005) (105)
- Frequent loss of WWOX expression in breast cancer: correlation with estrogen receptor status (2004) (105)
- Breast Cancer Molecular Signatures as Determined by SAGE: Correlation with Lymph Node Status (2007) (103)
- Concordance of Genomic Alterations between Primary and Recurrent Breast Cancer (2014) (102)
- Analysis of telomerase activity levels in breast cancer: positive detection at the in situ breast carcinoma stage. (1997) (101)
- Assessment of histologic features and expression of biomarkers in predicting pathologic response to anthracycline‐based neoadjuvant chemotherapy in patients with breast carcinoma (2002) (101)
- Aromatic DNA adducts and polymorphisms of CYP1A1, NAT2, and GSTM1 in breast cancer. (2002) (99)
- Functional proteomics can define prognosis and predict pathologic complete response in patients with breast cancer (2011) (99)
- SRC family kinases as novel therapeutic targets to treat breast cancer brain metastases. (2013) (99)
- High quality copy number and genotype data from FFPE samples using Molecular Inversion Probe (MIP) microarrays (2009) (99)
- Neoadjuvant chemotherapy for breast carcinoma (2003) (98)
- Multidisciplinary management of breast cancer concurrent with pregnancy. (2002) (98)
- Heregulin and HER2 signaling selectively activates c‐Src phosphorylation at tyrosine 215 (2003) (98)
- Global Gene Expression Changes During Neoadjuvant Chemotherapy for Human Breast Cancer (2002) (97)
- The Nuclear Transcription Factor κB/bcl-2 Pathway Correlates with Pathologic Complete Response to Doxorubicin-Based Neoadjuvant Chemotherapy in Human Breast Cancer (2005) (97)
- CD44 Expression Is Associated with Increased Survival in Node-Negative Invasive Breast Carcinoma (2005) (97)
- Revisiting the definition of estrogen receptor positivity in HER2-negative primary breast cancer (2017) (95)
- Detection of 2-amino-1-methyl-6-phenylimidazo[4,5-b]-pyridine-DNA adducts in normal breast tissues and risk of breast cancer. (2003) (95)
- Subunit 6 of the COP9 signalosome promotes tumorigenesis in mice through stabilization of MDM2 and is upregulated in human cancers. (2011) (95)
- Aberrant methylation and silencing of ARHI, an imprinted tumor suppressor gene in which the function is lost in breast cancers. (2003) (94)
- Sarcomatoid carcinoma of the lung. Immunohistochemieal and ultrastructural studies of 14 cases (1992) (93)
- Nodal status and clinical outcomes in a large cohort of patients with triple-negative breast cancer. (2011) (93)
- Clinical investigation: regional nodal failure patterns in breast cancer patients treated with mastectomy without radiotherapy. (2005) (93)
- Pathologic tumor size and lymph node status predict for different rates of locoregional recurrence after mastectomy for breast cancer patients treated with neoadjuvant versus adjuvant chemotherapy. (2002) (92)
- Novel staging system for predicting disease-specific survival in patients with breast cancer treated with surgery as the first intervention: time to modify the current American Joint Committee on Cancer staging system. (2011) (92)
- Ten-Year Outcomes of Patients With Breast Cancer With Cytologically Confirmed Axillary Lymph Node Metastases and Pathologic Complete Response After Primary Systemic Chemotherapy. (2016) (91)
- NHERF (Na+/H+ Exchanger Regulatory Factor) gene mutations in human breast cancer (2004) (89)
- The Neo-Bioscore Update for Staging Breast Cancer Treated With Neoadjuvant Chemotherapy: Incorporation of Prognostic Biologic Factors Into Staging After Treatment. (2016) (89)
- Locoregional recurrence after doxorubicin-based chemotherapy and postmastectomy: Implications for breast cancer patients with early-stage disease and predictors for recurrence after postmastectomy radiation. (2003) (89)
- Fascin, an actin-bundling protein associated with cell motility, is upregulated in hormone receptor negative breastancer (2000) (89)
- STK15/Aurora‐A expression in primary breast tumors is correlated with nuclear grade but not with prognosis (2004) (88)
- Contralateral prophylactic mastectomy (2004) (85)
- Jun activation domain binding protein 1 expression is associated with low p27(Kip1)levels in node-negative breast cancer. (2003) (83)
- Molecular prognostic factors for breast cancer metastasis and survival. (2002) (83)
- Molecular cloning and characterization of PELP1, a novel human coregulator of estrogen receptor alpha. (2001) (83)
- Dedicated cone-beam breast CT: feasibility study with surgical mastectomy specimens. (2007) (82)
- Analysis of dendritic cells in tumor-free and tumor-containing sentinel lymph nodes from patients with breast cancer (2004) (82)
- Estrogen/progesterone receptor negativity and HER2 positivity predict locoregional recurrence in patients with T1a,bN0 breast cancer. (2009) (81)
- Chemokine receptor CXCR4 expression in breast cancer as a potential predictive marker of isolated tumor cells in bone marrow (2005) (81)
- Fascin, an actin-bundling protein associated with cell motility, is upregulated in hormone receptor negative breast cancer (1999) (78)
- Chemokine receptors in advanced breast cancer: differential expression in metastatic disease sites with diagnostic and therapeutic implications. (2009) (76)
- Loss of aurora A/STK15/BTAK overexpression correlates with transition of in situ to invasive ductal carcinoma of the breast. (2003) (75)
- Recommendations for Sentinel Lymph Node Processing in Breast Cancer (2002) (75)
- Age and survival estimates in patients who have node-negative T1ab breast cancer by breast cancer subtype. (2011) (75)
- Comparison of risk of local-regional recurrence after mastectomy or breast conservation therapy for patients treated with neoadjuvant chemotherapy and radiation stratified according to a prognostic index score. (2005) (74)
- Ductal carcinoma in situ treated with lumpectomy and irradiation: histopathological analysis of 49 specimens with emphasis on risk factors and long term results. (1995) (74)
- Oxidative DNA damage and 8‐hydroxy‐2‐deoxyguanosine DNA glycosylase/apurinic lyase in human breast cancer (2001) (74)
- Invasive Breast Carcinoma (2014) (73)
- Loss of the expression of the tumor suppressor gene ARHI is associated with progression of breast cancer. (2003) (73)
- Multifunctional roles of insulin-like growth factor binding protein 5 in breast cancer (2008) (73)
- Clinical outcome of patients with lymph node‐negative breast carcinoma who have sentinel lymph node micrometastases detected by immunohistochemistry (2005) (72)
- Heregulin induces expression, ATPase activity, and nuclear localization of G3BP, a Ras signaling component, in human breast tumors. (2002) (72)
- Intraoperative touch imprint of sentinel lymph nodes in breast carcinoma patients (2002) (70)
- Mucocelelike tumor of the breast associated with atypical ductal hyperplasia or mucinous carcinoma. A clinicopathologic study of seven cases. (1991) (70)
- Polymorphisms and haplotypes of the NBS1 gene are associated with risk of sporadic breast cancer in non-Hispanic white women <or=55 years. (2006) (69)
- Interobserver Agreement Between Pathologists Assessing Tumor-Infiltrating Lymphocytes (TILs) in Breast Cancer Using Methodology Proposed by the International TILs Working Group (2016) (69)
- Pagetoid bowen disease: a report of 2 cases that express cytokeratin 7. (2000) (68)
- Tubular carcinoma of the breast. Predicting axillary nodal metastases and recurrence. (1996) (68)
- Her-2/neu gene amplification in ductal carcinoma in situ of the breast. (2002) (66)
- Flow cytometric analysis of the DNA content of non‐small cell lung cancer ploidy as a significant prognostic indicator in squamous cell carcinoma of the lung (1990) (66)
- Impact of low estrogen/progesterone receptor expression on survival outcomes in breast cancers previously classified as triple negative breast cancers (2012) (64)
- Disease‐free and overall survival after pathologic complete disease remission of cytologically proven inflammatory breast carcinoma axillary lymph node metastases after primary systemic chemotherapy (2006) (64)
- Biologic and Clinical Significance of HER‐2/neu (cerbB‐2) in Breast Cancer (2000) (64)
- Invasive mammary carcinoma with neuroendocrine differentiation: histological features and diagnostic challenges (2011) (63)
- Assessment of Two Automated Imaging Systems in Evaluating Estrogen Receptor Status in Breast Carcinoma (2007) (63)
- Cancer stem cell markers are enriched in normal tissue adjacent to triple negative breast cancer and inversely correlated with DNA repair deficiency (2013) (63)
- Comparison of Akt/mTOR signaling in primary breast tumors and matched distant metastases (2008) (63)
- β4 integrin subunit gene expression correlates with tumor size and nuclear grade in early breast cancer (2005) (63)
- Interobserver agreement for estrogen receptor immunohistochemical analysis in breast cancer: a comparison of manual and computer-assisted scoring methods. (2004) (62)
- Pseudosarcomatous fibromyxoid tumor of the urinary bladder and prostate: immunohistochemical, ultrastructural, and DNA flow cytometric analyses of nine cases. (1993) (62)
- Breast cancer with brain metastases: clinicopathologic features, survival, and paired biomarker analysis. (2015) (60)
- Promoter polymorphism (−786t>C) in the endothelial nitric oxide synthase gene is associated with risk of sporadic breast cancer in non‐Hispanic white women age younger than 55 years (2006) (60)
- The transcription factor ATF3 acts as an oncogene in mouse mammary tumorigenesis (2008) (58)
- IGFBP2 and IGFBP5 Overexpression Correlates With the Lymph Node Metastasis in T1 Breast Carcinomas (2008) (58)
- Aberrations in pseudoautosomal regions (PARs) found in infertile men with Y-chromosome microdeletions. (2011) (58)
- Combined Inhibition of STAT3 and DNA Repair in Palbociclib-Resistant ER-Positive Breast Cancer (2019) (58)
- Interobserver reproducibility of the Lagios nuclear grading system for ductal carcinoma in situ. (1999) (57)
- Tubular carcinoma of the breast: mammographic and sonographic features. (2000) (56)
- Novel estrogen receptor coactivator PELP1/MNAR gene and ERbeta expression in salivary duct adenocarcinoma: potential therapeutic targets. (2005) (56)
- MTA1 Interacts with MAT1, a Cyclin-dependent Kinase-activating Kinase Complex Ring Finger Factor, and Regulates Estrogen Receptor Transactivation Functions* (2003) (56)
- Automated quantification of apoptosis after neoadjuvant chemotherapy for breast cancer: early assessment predicts clinical response. (2003) (55)
- Identification of novel amplification gene targets in mouse and human breast cancer at a syntenic cluster mapping to mouse ch8A1 and human ch13q34. (2007) (55)
- Prognostic significance of tumor grading and staging in mammary carcinomas with neuroendocrine differentiation. (2011) (55)
- Leukemia inhibitory factor binds to human breast cancer cells and stimulates their proliferation. (1995) (54)
- Diagnostic utility of immunohistochemistry in distinguishing between epithelioid pleural mesotheliomas and breast carcinomas: a comparative study. (2014) (53)
- Proliferative and cytokine responses to class II HER-2/neu-associated peptides in breast cancer patients. (1998) (53)
- Definition of PKC-α, CDK6, and MET as therapeutic targets in triple-negative breast cancer. (2014) (52)
- Selective Genomic Copy Number Imbalances and Probability of Recurrence in Early-Stage Breast Cancer (2011) (52)
- Loss of Annexin A1 Expression in Breast Cancer Progression (2008) (52)
- Human breast cancer MCF-7 cell line contains inherently drug-resistant subclones with distinct genotypic and phenotypic features. (2002) (52)
- Decreased TGFβ signaling and increased COX2 expression in high risk women with increased mammographic breast density (2009) (52)
- Epidermal growth factor receptor expression correlates with poor survival in patients who have breast carcinoma treated with doxorubicin‐based neoadjuvant chemotherapy (2005) (51)
- Role of Specimen Radiography in Patients Treated With Skin-Sparing Mastectomy for Ductal Carcinoma In Situ of the Breast (2000) (51)
- Increased expression of CYP24A1 correlates with advanced stages of prostate cancer and can cause resistance to vitamin D3‐based therapies (2014) (50)
- Significantly higher pathological complete remission (PCR) rate following neoadjuvant therapy with trastuzumab (H), paclitaxel (P), and anthracycline-containing chemotherapy (CT): Initial results of a randomized trial in operable breast cancer (BC) with HER/2 positive disease. (2004) (49)
- Tumor proliferative fraction in solid malignant neoplasms. A comparative study of Ki-67 immunostaining and flow cytometric determinations. (1991) (49)
- Supplemental table 2 (2012) (48)
- Myofibroblastoma of the tongue. An immunohistochemical, ultrastructural, and flow cytometric study. (1990) (48)
- Endometrial tissue in myometrial vessels not associated with menstruation. (1989) (46)
- Evaluation of the stage IB designation of the American Joint Committee on Cancer staging system in breast cancer. (2015) (46)
- Cytoplasmic Cyclin E and Phospho-Cyclin-Dependent Kinase 2 Are Biomarkers of Aggressive Breast Cancer. (2016) (46)
- Prognostic factors in esophageal squamous carcinoma. A study of histologic features, blood group expression, and DNA ploidy. (1991) (46)
- The prognostic significance of sialyl‐tn Antigen in women treated with breast carcinoma treated with adjuvant chemotherapy (1997) (45)
- Ability to Generate Patient-Derived Breast Cancer Xenografts Is Enhanced in Chemoresistant Disease and Predicts Poor Patient Outcomes (2015) (45)
- Expression of erbB/HER receptors, heregulin and p38 in primary breast cancer using quantitative immunohistochemistry (2009) (45)
- TRPS1: a highly sensitive and specific marker for breast carcinoma, especially for triple-negative breast cancer (2020) (45)
- Multicentric mammary carcinoma (2002) (45)
- The subcellular localization of IGFBP5 affects its cell growth and migration functions in breast cancer (2009) (44)
- Breast pathology second review identifies clinically significant discrepancies in over 10% of patients (2015) (44)
- Influence of Biospecimen Variables on Proteomic Biomarkers in Breast Cancer (2014) (43)
- Impact of Identification of Internal Mammary Sentinel Lymph Node Metastasis in Breast Cancer Patients (2013) (42)
- Relationship between epidemiologic risk factors and breast cancer recurrence. (2007) (42)
- Quantitative nuclear morphometry by image analysis for prediction of recurrence of ductal carcinoma in situ of the breast. (2001) (42)
- Lymphovascular Invasion and Lobular Histology are Associated with Increased Incidence of Isolated Tumor Cells in Sentinel Lymph Nodes from Early-Stage Breast Cancer Patients (2008) (42)
- Phase II clinical trial of N-(4-Hydroxyphenyl)retinamide and tamoxifen administration before definitive surgery for breast neoplasia. (2002) (42)
- Reactivation of SYK expression by inhibition of DNA methylation suppresses breast cancer cell invasiveness (2005) (41)
- Cytoplasmic Cyclin E Predicts Recurrence in Patients with Breast Cancer (2016) (41)
- Efficacy of neoadjuvant therapy with trastuzumab concurrent with anthracycline‐ and nonanthracycline‐based regimens for HER2‐positive breast cancer (2012) (41)
- Cyclin E deregulation is an early event in the development of breast cancer (2009) (41)
- Survival Outcomes by TP53 Mutation Status in Metastatic Breast Cancer. (2018) (41)
- DCIS Margins and Breast Conservation: MD Anderson Cancer Center Multidisciplinary Practice Guidelines and Outcomes (2017) (41)
- Expression of sigma 1 receptor in human breast cancer (2004) (40)
- DEAR1 Is a Dominant Regulator of Acinar Morphogenesis and an Independent Predictor of Local Recurrence-Free Survival in Early-Onset Breast Cancer (2009) (40)
- HER-2/neu overexpression as a poor prognostic factor for patients with metastatic breast cancer undergoing high-dose chemotherapy with autologous stem cell transplantation. (2001) (40)
- Ductal Carcinoma-In-Situ: Long-Term Results of Breast-Conserving Therapy (2000) (40)
- E-cadherin immunohistochemical analysis of histiocytoid carcinoma of the breast. (2002) (39)
- Sphingosine-kinase-1 signaling promotes metastasis of triple-negative breast cancer. (2019) (39)
- Outcomes of Sentinel Lymph Node Dissection Alone vs. Axillary Lymph Node Dissection in Early Stage Invasive Lobular Carcinoma: A Retrospective Study of the Surveillance, Epidemiology and End Results (SEER) Database (2014) (38)
- DEAR1 is a chromosome 1p35 tumor suppressor and master regulator of TGF-β-driven epithelial-mesenchymal transition. (2013) (38)
- Beta4 integrin subunit gene expression correlates with tumor size and nuclear grade in early breast cancer. (2005) (38)
- Expression of leukemia inhibitory factor and its receptor in breast cancer: A potential autocrine and paracrine growth regulatory mechanism (1998) (38)
- Assessment of Ki-67-derived tumor proliferative activity in colorectal adenocarcinomas. (1994) (38)
- Myoepithelioma of the retroperitoneum. (1995) (38)
- Metastatic neuroendocrine tumour in the breast: a potential mimic of in‐situ and invasive mammary carcinoma (2011) (38)
- Sialyl-Tn antigen expression occurs early during human mammary carcinogenesis and is associated with high nuclear grade and aneuploidy. (1994) (37)
- Delays in Primary Surgical Treatment Are Not Associated With Significant Tumor Size Progression in Breast Cancer Patients (2011) (37)
- HER‐2/neu and p53 overexpression as biomarkers of breast carcinoma in women age 30 years and younger (2005) (36)
- Staging of breast cancer in the neoadjuvant setting. (2008) (36)
- Lower and central tumor location correlates with lymphoscintigraphy drainage to the internal mammary lymph nodes in breast carcinoma (2005) (35)
- CA 125 production in desmoplastic small round cell tumor: report of a case with elevated serum levels and prominent signet ring morphology. (1998) (35)
- Expression of c‐kit Proto‐Oncogene Product in Breast Tissue (2004) (35)
- Genetic and environmental determinants on tissue response to in vitro carcinogen exposure and risk of breast cancer. (2002) (35)
- Histologic Localization of Sentinel Lymph Node Metastases in Breast Cancer (2003) (34)
- The natural history of breast carcinoma in patients with ≥ 10 metastatic axillary lymph nodes before and after the advent of adjuvant therapy (2005) (34)
- Efficacy of neoadjuvant therapy with trastuzumab concurrent with anthracycline- and nonanthracycline-based regimens for HER2-positive breast cancer. (2011) (33)
- Increased gene copy number of the vesicle SNARE VAMP7 disrupts human male urogenital development through altered estrogen action (2014) (33)
- Her2/neu-positive disease does not increase risk of locoregional recurrence for patients treated with neoadjuvant doxorubicin-based chemotherapy, mastectomy, and radiotherapy. (2004) (32)
- Expression and Relevance of TRPS-1: A New GATA Transcription Factor in Breast Cancer (2011) (32)
- Loss of LRIG1 locus increases risk of early and late relapse of stage I/II breast cancer. (2014) (31)
- Atypical plant homeodomain of UBR7 functions as an H2BK120Ub ligase and breast tumor suppressor (2019) (31)
- Metastasis-associated protein 1 short form stimulates Wnt1 pathway in mammary epithelial and cancer cells. (2010) (30)
- Identification and biologic significance of micrometastases in axillary lymph nodes in patients with invasive breast cancer. (2009) (30)
- Radiologic-pathologic conferences of the University of Texas M.D. Anderson Cancer Center. Phyllodes tumor of the breast. (2003) (30)
- HER2 Regulation of Peroxisome Proliferator-activated Receptor γ (PPARγ) Expression and Sensitivity of Breast Cancer Cells to PPARγ Ligand Therapy (2003) (30)
- Factors predictive of having four or more positive axillary lymph nodes in patients with positive sentinel lymph nodes: implications for selection of radiation fields. (2004) (30)
- Multigene clinical mutational profiling of breast carcinoma using next-generation sequencing. (2015) (30)
- Temporal bone involvement by prostatic adenocarcinoma: Report of two cases and review of the literature (1991) (29)
- Telomerase in Breast Cancer: A Critical Evaluation (2004) (29)
- SU2C phase Ib study of paclitaxel and MK-2206 in advanced solid tumors and metastatic breast cancer. (2015) (29)
- Locoregional treatment outcomes for breast cancer patients with ipsilateral supraclavicular metastases at diagnosis. (2007) (29)
- Quantitative Immunohistochemical Analysis and Prognostic Significance of TRPS-1, a New GATA Transcription Factor Family Member, in Breast Cancer (2010) (29)
- Expression of sigma 1 receptor in human breast cancer (2004) (29)
- Interphase cytogenetics in mammographically detected breast lesions. (1996) (28)
- Vascular endothelial growth factor and Kaposi's sarcoma cells in human skin grafts. (2002) (28)
- Genitourinary Defects Associated with Genomic Deletions in 2p15 Encompassing OTX1 (2014) (28)
- Metaplastic Breast Carcinomas: Are They of Myoepithelial Differentiation? Immunohistochemical Profile of the Sarcomatoid Subtype Using Novel Myoepithelial Markers (2006) (28)
- Pseudoangiomatous stromal hyperplasia of the breast. (2002) (28)
- High Intratumoral Stromal Content Defines Reactive Breast Cancer as a Low-risk Breast Cancer Subtype (2016) (27)
- The relationship between eight GWAS-identified single-nucleotide polymorphisms and primary breast cancer outcomes. (2013) (27)
- Lung carcinoma with metastasis to testicular seminoma (1990) (27)
- Nuclear factor-&kgr;B as a predictor of treatment response in breast cancer (2003) (27)
- Novel translational model for breast cancer chemoprevention study: accrual to a presurgical intervention with tamoxifen and N-[4-hydroxyphenyl] retinamide. (2000) (26)
- Intraductal Proliferative Lesions (2017) (26)
- Dissection of Signaling Pathways in Fourteen Breast Cancer Cell Lines Using Reverse-Phase Protein Lysate Microarray (2006) (26)
- Aurora kinase-A overexpression in mouse mammary epithelium induces mammary adenocarcinomas harboring genetic alterations shared with human breast cancer. (2016) (26)
- Biologic markers in axillary node-negative breast cancer: differential expression in invasive ductal carcinoma versus invasive lobular carcinoma. (2006) (26)
- Prognostic significance of occult axillary lymph node metastases after chemotherapy‐induced pathologic complete response of cytologically proven axillary lymph node metastases from breast cancer (2009) (26)
- Glutathione-S-Transferase-Pi Expression in Early Breast Cancer: Association With Outcome and Response to Chemotherapy (2010) (25)
- Basal cell carcinoma with hyaline inclusions. (1989) (25)
- Impact of concurrent proliferative high‐risk lesions on the risk of ipsilateral breast carcinoma recurrence and contralateral breast carcinoma development in patients with ductal carcinoma in situ treated with breast‐conserving therapy (2006) (25)
- Towards a transcriptome-based theranostic platform for unfavorable breast cancer phenotypes (2016) (25)
- Association with Trastuzumab Response and Survival in Patients with HER2-Positive Metastatic Breast Cancer (2010) (24)
- Invasive Ductal Carcinoma (1998) (23)
- Comparative Study of Breast Cancer in Mexican and Mexican-American Women (2010) (23)
- Axillary lymph node cellular immune response to HER-2/neu peptides in patients with carcinoma of the breast. (2002) (23)
- Phase III randomized trial of dose intensive neoadjuvant chemotherapy with or without G-CSF in locally advanced breast cancer: long-term results. (2011) (23)
- Hormone receptor status influences the locoregional benefit of trastuzumab in patients with nonmetastatic breast cancer (2012) (22)
- CCR 7 and CXCR 4 as Novel Biomarkers Predicting Axillary Lymph NodeMetastasis in T 1 Breast Cancer (2005) (22)
- Comparison of full-field digital mammography and screen-film mammography for detection and characterization of simulated small masses. (2006) (21)
- Biobanking in genomic medicine. (2015) (21)
- Paneth cell-like eosinophilic cytoplasmic granules in breast carcinoma. (2011) (21)
- Elafin is downregulated during breast and ovarian tumorigenesis but its residual expression predicts recurrence (2014) (21)
- Digital Breast Tomosynthesis for Intraoperative Margin Assessment during Breast-Conserving Surgery (2019) (21)
- Expanding Implementation of ACOSOG Z0011 in Surgeon Practice (2018) (21)
- Decreased TGFβ signaling and increased COX2 expression in high risk women with increased mammographic breast density. (2009) (20)
- Mucinous adenocarcinoma of the prostate with endobronchial metastasis. (1990) (20)
- Significant increased recurrence rates among breast cancer patients with HER2-positive, T1a,bN0M0 tumors. (2009) (20)
- Non-glycanated Decorin Is a Drug Target on Human Adipose Stromal Cells (2017) (20)
- Copy Number Imbalances between Screen- and Symptom-Detected Breast Cancers and Impact on Disease-Free Survival (2011) (20)
- Association between germline single nucleotide polymorphisms in the PI3K-AKT-mTOR pathway, obesity, and breast cancer disease-free survival (2014) (19)
- Clinical outcomes based on multigene profiling in metastatic breast cancer patients (2016) (19)
- Genome-wide copy number aberrations and HER2 and FGFR1 alterations in primary breast cancer by molecular inversion probe microarray (2017) (19)
- Expression of PEA3 and Lack of Correlation Between PEA3 and HER-2/neu Expression in Breast Cancer (2006) (19)
- Granular cell tumor of the biliary tree. (1992) (19)
- Chromosome in situ hybridization on formalin-fixed mammary tissue using non-isotopic, non-fluorescent probes: technical considerations and biological implications. (1992) (19)
- Prognostic value of single nucleotide polymorphisms of candidate genes associated with inflammation in early stage breast cancer (2013) (18)
- Expression of PD-1 and PD-L1 in Extramammary Paget Disease: Implications for Immune-Targeted Therapy (2019) (18)
- Heparin/heparan sulfate interacting protein expression and functions in human breast cancer cells and normal breast epithelia. (1997) (18)
- Nomogram to predict pathologic complete response in HER2-positive breast cancer treated with neoadjuvant systemic therapy (2017) (18)
- MicroRNA-17 Acts as a Tumor Chemosensitizer by Targeting JAB1/CSN5 in Triple-Negative Breast Cancer. (2019) (17)
- Spindle cell nodule and peptic ulcer arising in a fully developed gastric wall in a mature cystic teratoma. (1990) (17)
- Alveolar soft part sarcoma of the uterine cervix. (1989) (17)
- Loss of Aurora A / STK 15 / BTAK Overexpression Correlates with Transition of in Situ to Invasive Ductal Carcinoma of the Breast (2003) (17)
- Breast carcinoma with choriocarcinomatous features. (2004) (16)
- PI 3 K Pathway Mutations and PTEN Levels in Primary and Metastatic Breast Cancer (2011) (16)
- Genetic variants in the vitamin D pathway and breast cancer disease-free survival. (2013) (16)
- Malignant Melanoma Metastatic to Gastrointestinal Tract (1994) (16)
- The prognostic significance of flow cytometric DNA analysis (1992) (16)
- Prospective Registry Trial Assessing the Use of Magnetic Seeds to Locate Clipped Nodes After Neoadjuvant Chemotherapy for Breast Cancer Patients (2021) (16)
- Distinct function of androgen receptor coactivator ARA70α and ARA70β in mammary gland development, and in breast cancer (2011) (15)
- Nuclear factor-kappa B as a predictor of treatment response in breast cancer. (2003) (15)
- Anti-GD2 antibody dinutuximab inhibits triple-negative breast tumor growth by targeting GD2+ breast cancer stem-like cells (2021) (15)
- Environmentally-induced malignant pleural mesothelioma and HLA distribution in Turkey. (1998) (14)
- Identification of a novel estrogen receptor-alpha variant and its upstream splicing regulator. (2010) (14)
- Prognostic value of the trichorhinophalangeal syndrome-1 (TRPS-1), a GATA family transcription factor, in early-stage breast cancer. (2013) (14)
- Supplemental Table S1 (2015) (14)
- HER2 regulation of peroxisome proliferator-activated receptor gamma (PPARgamma) expression and sensitivity of breast cancer cells to PPARgamma ligand therapy. (2003) (14)
- Patients with only 1 positive hormone receptor have increased locoregional recurrence compared with patients with estrogen receptor‐positive progesterone receptor‐positive disease in very early stage breast cancer (2011) (14)
- African American patients with breast cancer have worse prognosis than white patients in certain subtypes and stages (2017) (13)
- Molecular profiles of invasive mucinous and ductal carcinomas of the breast: a molecular case study. (2003) (13)
- Human telomerase reverse transcriptase mRNA is highly expressed in normal breast tissues and down-regulated in ductal carcinoma in situ. (2004) (13)
- Long-Term Impact of Regional Nodal Irradiation in Patients With Node-Positive Breast Cancer Treated With Neoadjuvant Systemic Therapy. (2018) (13)
- Mucinous Lesions of the Breast. (2009) (13)
- Parathyroid adenoma of the mediastinum. (1999) (12)
- Atlas of Differential Diagnosis in Breast Pathology (2017) (12)
- Is it too soon to start reporting HER2 genetic heterogeneity? (2010) (12)
- Intraluminal crystalloids in struma ovarii. Immunohistochemical, DNA flow cytometric, and ultrastructural study. (1991) (11)
- Strategies for the application of biomarkers for risk assessment and efficacy in breast cancer chemoprevention trials (1993) (11)
- Too much, too little, or just right? Tumor margins in women undergoing breast-conserving surgery. (2014) (11)
- CD8+ T cells inhibit metastasis and CXCL4 regulates its function (2021) (11)
- Multidisciplinary Intraoperative Assessment of Breast Specimens Reduces Number of Positive Margins (2018) (11)
- Phase 2 trial of primary systemic therapy with doxorubicin and docetaxel followed by surgery, radiotherapy, and adjuvant chemotherapy with cyclophosphamide, methotrexate, and 5‐fluorouracil based on clinical and pathologic response in patients with stage IIB to III breast cancer (2010) (10)
- Y-chromosome microdeletions are not associated with SHOX haploinsufficiency. (2014) (10)
- p53 and c-erbB-2 expression and response to preoperative chemotherapy in locally advanced breast carcinoma (1995) (10)
- Clinicopathologic factors associated with involved margins after breast-conserving surgery for invasive lobular carcinoma. (2010) (10)
- HER2 somatic mutation analysis in breast cancer: correlation with clinicopathological features. (2019) (10)
- Elevated expression of hepatic proliferative markers during early hepatocarcinogenesis in hepatitis‐B virus transgenic mice lacking mdr1a‐encoded P‐glycoprotein (2000) (10)
- Intraluminal crystalloids in breast carcinoma. Immunohistochemical, ultrastructural, and energy-dispersive x-ray element analysis in four cases. (1997) (10)
- Metastatic Tumor Volume and Extranodal Tumor Extension: Clinical Significance in Patients With Stage II Breast Cancer. (2015) (10)
- Challenges With the 8th Edition of the AJCC Cancer Staging Manual for Breast, Testicular, and Head and Neck Cancers. (2019) (9)
- Effectiveness and Safety of Magseed-localization for Excision of Breast Lesions: A Prospective, Phase IV Trial. (2020) (9)
- Technical approach for the study of the genetic evolution of breast cancer from paraffin-embedded tissue sections (2005) (9)
- Computerized image analysis of Ki-67 in ductal breast carcinoma in situ. (2001) (9)
- Occult axillary lymph node metastases do not have prognostic significance in early stage breast cancer (2012) (8)
- Genomic copy number imbalances associated with bone and non-bone metastasis of early-stage breast cancer (2013) (8)
- Targeting Replicative Stress and DNA Repair by Combining PARP and Wee1 Kinase Inhibitors Is Synergistic in Triple Negative Breast Cancers with Cyclin E or BRCA1 Alteration (2021) (8)
- p21-Activated Kinase 1 Regulates Microtubule Dynamics by Phosphorylating Tubulin Cofactor B (2013) (8)
- Erratum: A case-control study of unilateral and bilateral breast carcinoma patients (Cancer (2001) 91 (1845-1853)) (2002) (7)
- Abstract P3-10-41: Quantitative Immunohistochemical Analysis and Prognostic Significance of TRPS-1, a New GATA Transcription Factor Family Member, in Breast Cancer (2010) (7)
- TRPS1, GATA3, and SOX10 expression in triple-negative breast carcinoma. (2022) (7)
- Radiation treatment improves local-regional control and survival in patients with locally advanced breast cancer treated with neoadjuvant chemotherapy and mastectomy (2003) (7)
- Prognostic Factors for Invasive Breast Cancer (1999) (7)
- Chromogenic In Situ Hybridization for α6β4 Integrin in Breast Cancer: Correlation with Protein Expression (2004) (7)
- No increased Ki67 expression in ductal carcinoma in situ associated with invasive breast cancer. (2001) (7)
- Comparing breast biomarker status between routine immunohistochemistry and FISH studies and Oncotype DX testing, a study of 610 cases (2018) (7)
- Enterobiasis of the Ovary in a Patient With Cervical Carcinoma In Situ (1995) (7)
- A comparative analysis of core needle biopsy and final excision for breast cancer: Histology and marker expression: Ough M, Velasco J, Hieken TJ (NorthShore Univ Healthcare System, Skokie, IL) Am J Surg 201:685-687, 2011 (2012) (7)
- Pseudosarcomatous Fibromyxoid Tumor of the Prostate: A Case Report with Immunohistochemical, Electron Microscopic, and DNA Flow Cytometric Analysis (1991) (7)
- Residual tumor thickness at the tumor-normal tissue interface predicts the recurrence-free survival in patients with liver metastasis of breast cancer. (2014) (6)
- Association of fragile site-associated (FSA) gene expression with epithelial differentiation and tumor development. (2006) (6)
- Chromogenic in situ hybridization for alpha6beta4 integrin in breast cancer: correlation with protein expression. (2004) (6)
- Chromosomein situ hybridization on formalin-fixed mammary tissue using non-isotopic, non-fluorescent probes: technical considerations and biological implications (1992) (6)
- Clinical outcomes based on multigene profiling in metastatic breast cancer patients. (2015) (6)
- Evaluation of Prognosis in Hormone Receptor–Positive/HER2‐Negative and Lymph Node–Negative Breast Cancer With Low Oncotype DX Recurrence Score (2017) (5)
- Genomic, Transcriptomic, and Proteomic Profiling of Metastatic Breast Cancer (2021) (5)
- Invasive ductal carcinoma of the breast with a microglandular adenosis pattern. (2004) (5)
- Erratum: Ability to generate patient-derived breast cancer xenografts is enhanced in chemoresistant disease and predicts poor patient outcomes (PLoS ONE (2015) 10:9 (e0136851) DOI: 10.1371/journal.pone.0136851) (2016) (5)
- Metastatic cervical cancer presenting as cholecystitis. (1994) (5)
- Correction: Ability to Generate Patient-Derived Breast Cancer Xenografts Is Enhanced in Chemoresistant Disease and Predicts Poor Patient Outcomes (2016) (4)
- Prognostic and Predictive Factors of Invasive Breast Cancer (2016) (4)
- The impact of Ki-67 in the context of multidisciplinary care in primary inflammatory breast cancer (2019) (4)
- Relationship between implementation of the American Society of Clinical Oncology/College of American Pathologists guideline recommendations for breast core-needle biopsies and delay in therapy for patients with breast cancer. (2011) (4)
- A 95-gene signature stratifies recurrence risk of invasive disease in ER-positive, HER2-negative, node-negative breast cancer with intermediate 21-gene signature recurrence scores (2021) (4)
- Quantitative Estrogen Receptor Immunohistochemical Analysis of Breast Cancer: Advantages and Potential Problems (1996) (4)
- Erratum to Dynein Light Chain 1, a p21-Activated Kinase 1-Interacting Substrate, Promotes Cancerous Phenotypes [Cancer Cell, 5 (2004) 575-585] (2004) (4)
- Effector memory cytotoxic CD3+/CD8+/CD45RO+ T cells are predictive of good survival and a lower risk of recurrence in triple-negative breast cancer (2021) (4)
- Expression of CXCR4 predicts lymph node metastasis in early breast cancer. (2004) (4)
- Definition of PKC-α , CDK 6 , and MET as therapeutic targets in triple-negative breast cancer (2014) (4)
- Beyond TILs: Predictors of pathologic complete response (pCR) in triple-negative breast cancer (TNBC) patients with moderate tumor-infiltrating lymphocytes (TIL) receiving neoadjuvant therapy. (2019) (4)
- Her2-Neu overexpression does not increase the risk of local-regional recurrence for patients treated with neoadjuvant doxorubicin-based chemotherapy, mastectomy, and radiation (2003) (3)
- Phyllodes tumor of the breast (2003) (3)
- Cytoplasmic Cyclin E Expression Predicts for Response to Neoadjuvant Chemotherapy in Breast Cancer (2019) (3)
- Stimulation of cells from a non-invaded and an invaded lymph node with a HER-2+ tumor with peptides corresponding to T-cell epitopes E75 and G89 induced expansion of central memory cells (TCM) from the metastasis-negative lymph nodes. (2004) (3)
- MTA1 Interacts with MAT1, a CAK Complex Ring Finger Factor, and Regulates Estrogen Receptor Transactivation Functions * (2003) (3)
- Prior systemic treatment increased the incidence of somatic mutations in metastatic breast cancer. (2018) (3)
- Morphologic assessment of tumor proliferative fraction (1993) (3)
- E-cadherin Expression Loss in T1 Invasive Ductal Carcinoma of the Breast as a Predictive Marker for Lymph Node Metastasis (2005) (3)
- Metastatic non-Hematopoietic Neoplasms to the Breast: A Study of 238 Cases. (2022) (3)
- Phyllodes tumors of the breast (1995) (3)
- TRPS1, GATA3, and SOX10 Expression in Triple-Negative Breast Carcinoma (2022) (3)
- Impact of routine pathology review on treatment for node-negative breast cancer: Kennecke HF, Speers CH, Ennis CA, et al (British Columbia Cancer Agency, Canada) J Clin Oncol 30:2227-2231, 2012 (2013) (3)
- P53 alterations show significant correlation with gene amplification and s-phase index in breast-cancer. (1995) (3)
- Histopathological Features of Non-Neoplastic Breast Parenchyma Do Not Predict BRCA Mutation Status of Patients with Invasive Breast Cancer (2015) (2)
- Granular cell tumor of the breast: Sonographic and histologic patterns (1996) (2)
- Radiation is an Important Component of Therapy for Patients with Stage III Breast Cancer Who Achieve a Pathological Complete Response after Neoadjuvant Chemotherapy (2005) (2)
- Correction: Transcriptomic changes in human breast cancer progression as determined by serial analysis of gene expression (2004) (2)
- Breast cancer evaluation and targeted investigational therapy (BEAT-IT): A pilot prospective tissue testing to guide clinical trial selection. (2013) (2)
- Long-term outcome of patients with complete eradication of cytologically proven axillary node metastases after primary chemotherapy: The University of Texas M. D. Anderson Cancer Center experience (2004) (2)
- Abstract P1-07-06: Effect of biospecimen variables on proteomic biomarker assessment in breast cancer (2012) (2)
- Sentinel lymph node histopathology in breast cancer [1] (multiple letters) (2002) (2)
- Abstract LB-202: 14-3-3ζ turns TGF-β's function from tumor suppressor to metastasis promoter in breast cancer by contextual changes of Smad partners from p53 to Gli2 (2015) (2)
- Impact of low estrogen- and progesterone-receptor expression on survival outcomes in breast cancers previously classified as triple-negative breast cancers. (2011) (2)
- Rate of reclassification of HER2-equivocal breast cancer cases to HER2-negative per the 2018 ASCO/CAP guidelines and response of HER2-equivocal cases to anti-HER2 therapy (2020) (2)
- Clinicopathological features of and neoadjuvant therapy for HER2-positive classic invasive lobular carcinoma. (2021) (2)
- Clinicopathological Features of Breast Cancer with Polysomy 17 and Its Response to Neoadjuvant Chemotherapy. (2021) (2)
- Prognostic Impact of High Baseline Stromal Tumor-Infiltrating Lymphocytes in the Absence of Pathologic Complete Response in Early-Stage Triple-Negative Breast Cancer (2022) (1)
- Male Mammary Paget Disease: A Tale of 2 Contrasting Cases. (2020) (1)
- Outcomes differences in tumors < 1 cm by age and breast cancer subtype. (2010) (1)
- Abstract LB-379: Combating trastuzumab resistance by targeting Src, a common node downstream of multiple resistance pathways (2011) (1)
- 14-3-3 z Cooperates with ErbB 2 to Promote Ductal Carcinoma In Situ Progression to Invasive Breast Cancer by Inducing Epithelial-Mesenchymal Transition (2009) (1)
- Immunohistochemical expression of TRPS1 in mammary Paget disease, extramammary Paget disease, and their close histopathologic mimics (2023) (1)
- Utility of a One-Step Nucleic Acid Amplification (OSNA) Assay for Comprehensive Examination of Axillary Lymph Nodes in Breast Cancer. (2009) (1)
- Age and Associated Fibrocystic Changes are Prognostically Significant in Patients with Small Node‐Negative (T1a,bN0) Invasive Breast Cancer (2011) (1)
- Sentinel lymph node histopathology in breast cancer. Authors' reply (2002) (1)
- Pathological evaluation of axillary sentinel lymph nodes in breast cancer. (2006) (1)
- Molecular Medicine in Practice PI 3 K Pathway Mutations and PTEN Levels in Primary and Metastatic Breast Cancer (2011) (1)
- Molecular inversion probe technology generates high-quality HER2 copy number data in formalin-fixed paraffin-embedded breast cancer tissue (2016) (1)
- Erratum to: Elafin is downregulated during breast and ovarian tumorigenesis but its residual expression predicts recurrence (2015) (1)
- Clinical Outcomes Using Magnetic Seeds as a Non-wire, Non-radioactive Alternative for Localization of Non-palpable Breast Lesions (2022) (1)
- Abstract A78: The Ella Binational Breast Cancer Study: Risk factor and tumor marker profile in women of Mexican ancestry (2009) (1)
- Glutathione S‐Transferase‐pi Expression in Prechemotherapy and Postchemotherapy Tumor Samples from Patients with Locally Advanced Breast Carcinomas (1996) (1)
- Sentinel Lymph Node Histopathology in Breast Cancer (2002) (1)
- EVALUATION OF SENTINEL LYMPH NODES (1)
- Molecular classification and testing of breast carcinoma (2014) (1)
- Tumor-associated nonmyelinating Schwann cell–expressed PVT1 promotes pancreatic cancer kynurenine pathway and tumor immune exclusion (2023) (1)
- Crosstalk between CXCR4 and HER2-neu in breast cancer: Transactivation of HER2-neu by stromal derived factor-1 alpha through Src kinase activation (2004) (1)
- No Increased Ki 67 Expression in Ductal Carcinoma in Situ Associated with Invasive Breast Cancer 1 (2001) (1)
- Diagnosis and biomarkers (2014) (1)
- Abstract #3822: PDK1-SGK3 signaling in the absence of AKT activation in PIK3CA- mutant cancers (2009) (1)
- Regional Management of Breast Cancer (2010) (1)
- Short Communication Loss of Aurora A/STK15/BTAK Overexpression Correlates with Transition of in Situ to Invasive Ductal Carcinoma of the Breast (2003) (1)
- Pathologic assessment of prognostic factors in patients with operable breast cancer (1993) (1)
- Immunohistochemical Markers for Distinguishing Metastatic Breast Carcinoma from Other Common Malignancies: Update and Revisit. (2022) (1)
- Abstract P3-10-23: Changes in the expression of HER2 and other genes in HER2-positive metastatic breast cancer induced by treatment with ado-trastuzumab emtansine and/or pertuzumab/trastuzumab (2019) (1)
- Expression of CXCR4 predicts lymph node metastasis in early breast cancer (2004) (1)
- A novel 95-gene signature (Curebest 95GC Breast) that predicts recurrence-risk in patients with ER-positive, HER2-negative, node-negative, early-stage primary invasive breast cancer with an intermediate Oncotype DX Recurrence Score. (2019) (1)
- Validation of a novel staging system for breast cancer patients treated with neoadjuvant chemotherapy. (2016) (1)
- The pattern of chemokine receptors expressed by tumor cells predicts the site of metastatic relapse in patients with axillary node positive breast cancer (2005) (1)
- 1–21 Pathologic Features of Breast Cancer Associated With Complete Response to Neoadjuvant Chemotherapy: Importance of Tumor Necrosis (2006) (1)
- Abstract A55: Breast cancer detection and screening mammography in Mexican American women: Findings from the Ella Binational Breast Cancer Study (2009) (0)
- Evaluation of the stage IB designation of the 7th edition of the AJCC Staging System. (2012) (0)
- Abstract P4-07-13: An exploratory case-control study of perineural invasion in breast cancer (2022) (0)
- High level of STK-15 expression in primary breast tumors correlates with nuclear grade (2001) (0)
- 14-3-3 z TurnsTGF-b ’ s Func tion fromTumorSuppressor toMetastasis Promoter in Breast Cancer by Contextual Changes of Smad Partners from p 53 to Gli 2 Graphical (2015) (0)
- Abstract P2-09-02: Validation of a Novel Staging System for Disease-Specific Survival in Breast Cancer Patients Treated with Neoadjuvant Chemotherapy (2010) (0)
- Evaluation of predictive biomarkers for AR therapy and to identify the LAR subtype of TNBC. (2019) (0)
- Identification and validation of aberrantly expressed proteins in breast ductal carcinoma in situ (DCIS) and esophageal squamous cell carcinoma (ESCC) (2002) (0)
- Tumor suppressor DEAR1 regulates mammary epithelial cell fate and predicts early onset and metastasis in triple negative breast cancer (2022) (0)
- Histopathologic evaluation of breast specimens after neoadjuvant chemotherapy (2015) (0)
- Male breast cancer: Clinico-pathological study with evaluation of biologic markers. (2004) (0)
- Schematic model portraying some of the most significant transcriptomic changes observed in breast ca (2011) (0)
- Integration of specific copy number imbalances and prediction models of early-stage breast cancer recurrence. (2010) (0)
- Elafin is downregulated during breast and ovarian tumorigenesis but its residual expression predicts recurrence (2014) (0)
- Genetic and Environmental Determinants on Tissue Response to in Vitro Carcinogen Exposure and Risk of Breast Cancer 1 (2002) (0)
- Vascular Endothelial Growth Factor and Kaposi ’ s Sarcoma Cells in Human Skin Grafts 1 (2002) (0)
- Treatment-Related Changes (2017) (0)
- The pathologists and team at PhenoPath (2016) (0)
- Clinicopathologic factors associated with involved margins following breast conserving surgery for invasive lobular carcinoma (ILC). (2009) (0)
- Abstract PS18-37: Loss of Trop2 protein in metaplastic carcinoma of breast by IHC (2021) (0)
- E-cadherin Expression Loss in T 1 Invasive Ductal Carcinoma of the Breast as a Predictive Marker for Lymph Node Metastasis (2005) (0)
- Lobular Lesions (Lobular Neoplasia, Invasive Lobular Carcinoma) (2017) (0)
- Epidemiological risk factors for breast cancer recurrence according to estrogen and progesterone receptor status (2007) (0)
- TRPS1 and GATA3 Expression in Invasive Breast Carcinoma With Apocrine Differentiation. (2023) (0)
- Effect of modest delays in primary surgical treatment on progression of tumor size in breast cancer patients. (2009) (0)
- For Peer Review Genetic variants in the vitamin D pathway and breast cancer disease-free survival (2012) (0)
- Cyclooxygenase-2 Expression in Human Breast Cancers and Adjacent Ductal Carcinoma in Situ 1 (2002) (0)
- Abstract P1-05-05: eEF1A2 facilitates PTEN-GSK3β mediated Aurora-A protein degradation during S-G2 phase inactivated in PTEN-deficient breast cancer (2019) (0)
- Abstract P4-10-22: Loss of androgen receptor after neoadjuvant anti-HER2 therapy in patients with locally advanced HER2-positive breast cancer (2020) (0)
- High risk CNIs, race and early stage breast cancer (2013) (0)
- Investigation of ethnic differences in the prevalence of chromosomal number aberrations of luminal and triple-negative breast cancers associated with risk of recurrence. (2010) (0)
- Hierarchical clustering of the most commonly different expressed genes between normal breast tissue (2011) (0)
- Abstract P2-21-07: Exploring spatial correlations in Breast invasive Lobular Carcinoma subtypes using a novel CAF multiplex immunofluorescence panel (2023) (0)
- A novel staging system for disease-specific survival in patients with breast cancer treated with surgery as the first intervention. (2011) (0)
- HER-2/neu Gene Amplification in Ductal Carcinoma In Situ of the Breast 1 (2002) (0)
- Erratum: Expression of sigma 1 receptor in human breast cancer (Breast Cancer Research and Treatment (2004) 87 (205-214)) (2005) (0)
- Abstract 1798: Mechanisms of acquired resistance to palbociclib reveals pathways of response to abemaciclib (2022) (0)
- Biomarkers in Breast Carcinomas (2022) (0)
- COP 9 signalosome subunit 6 promotes tumorigenesis through stabilization of MDM 2 (2010) (0)
- Breast Cancer With a HER2 FISH Group 2 Result: Should HER2 Tests be Repeated? (2023) (0)
- HER 2 Regulation of Peroxisome Proliferator-activated Receptor ( PPAR ) Expression and Sensitivity of Breast Cancer Cells to PPAR Ligand Therapy 1 (2003) (0)
- Treatment of Metastatic Breast Carcinoma Refractory to Doxorubicin with Liposomal-Annamycin (2000) (0)
- Abstract A61: Prognostic relevance of genome-wide association studies-identified single nucleotide polymorphisms in primary breast cancer (2011) (0)
- Prognostic Role of aMultigene ReverseTranscriptase-PCRAssay in Patients with Node-Negative Breast Cancer Not Receiving Adjuvant (2005) (0)
- Association of gene copy number alterations in formalin-fixed, paraffin-embedded tumors with prognostic molecular and pathologic tumor subtypes in early-stage breast cancer. (2010) (0)
- Author reply (0)
- P5-03-01: Cytoplasmic Cyclin E and P-CDK2 Expression in Triple Negative Breast Carcinomas Measured by Immunohistochemistry Correlates with Poor Outcome. (2011) (0)
- Epidemiologic risk factors associated with breast cancer subtypes. (2010) (0)
- Applicability of the American College of Surgeons Oncology Group (ACOSOG) Z0011 trial results in invasive lobular carcinoma. (2013) (0)
- Chromothripsis-Like Pattern in Chromosome 17q12 Is Associated with HER2 Amplification in Breast Cancer (2016) (0)
- Companion Diagnostics and Cancer Biomarkers Concordance of Genomic Alterations between Primary and Recurrent Breast Cancer (2014) (0)
- Abstract LB-095: Aurora-A is elevated in cancer cells due to inactivation of EF1A2-PTEN-GSK3b regulated late S-G2 phase specific degradation pathway (2019) (0)
- Abstract P1-08-09: Aurora kinase-A protein stability is negatively regulated by eEF1α2 and PTEN in breast cancer: Prognostic and therapeutic implications (2017) (0)
- Supplemental table 3 (2015) (0)
- Abstract B231: Jab1/Csn5 a new player driving the resistance to Her2-targeted therapies for breast cancer. (2013) (0)
- Metastatic Tumor Volume and Extranodal Tumor Extension (2015) (0)
- Hierarchical clustering of the most commonly differentially expressed genes between ductal carcinoma (2011) (0)
- Reporting of Surgically Removed Lymph Nodes for Breast Tumors: Recommendations From the International Collaboration on Cancer Reporting. (2022) (0)
- Breast Cancers Tumor Suppressor Gene in which the Function Is Lost in , an Imprinted ARHI Aberrant Methylation and Silencing of Updated (2003) (0)
- Herceptin Plus Chemotherapy Combination in Preoperative Regimen May Offer Clinical Benefit in Early Stage Breast Cancer (2005) (0)
- In reply [2] (2006) (0)
- Abstract LB-106: Expression of stem cell biomarkers in benign breast tissue from patients with triple negative breast cancer (2011) (0)
- SOX17: A Highly Sensitive and Specific Immunomarker for Ovarian and Endometrial Carcinomas. (2023) (0)
- Abstract 1912: Jab1/Csn5 as a novel driver for therapeutic resistance in HER2-positive breast cancer (2012) (0)
- Correction to: Clinical Outcomes Using Magnetic Seeds as a Non-wire, Non-radioactive Alternative for Localization of Non-palpable Breast Lesions (2022) (0)
- Abstract PS18-04: Prospective evaluation of patients with metaplastic (Mp) triple negative breast cancer (TNBC): Molecular characteristics and outcomes with neoadjuvant therapy (NAT) (2021) (0)
- Stage I / II Breast Cancer Locus Increases Risk of Early and Late Relapse of LRIG 1 Loss of Updated (2014) (0)
- Developmental, Reactive, and Inflammatory Conditions (2017) (0)
- Mutations in Homologous Recombination Genes and Loss of Heterozygosity Status in Advanced-Stage Breast Carcinoma (2023) (0)
- Overexpressed DLC1 as Target for Breast Cancer Cell Shape and Survival (2004) (0)
- Abstract P1-18-20: Breast cancer with HER2 FISH test result in group 2: Should HER2 test be repeated? (2020) (0)
- Sentinel L ymph N ode B iopsy I s A ccurate A fter N eoadjuvant Chemotherapy f or B reast C ancer (2000) (0)
- Abstract P3-08-38: Primary cutaneous melanoma of the breast in women. A retrospective study of 82 patients (2020) (0)
- Tubulin Cofactor B Microtubule Dynamics by Phosphorylating p 21-Activated Kinase 1 Regulates (2005) (0)
- Abstract P3-10-23: Caveolin 1 and Patient Outcomes in Breast Cancer (2010) (0)
- 1616 CHROMOSOME 13Q A SUSCEPTIBILITY LOCUS FOR EPISPADIAS (2012) (0)
- Ask the Experts: Axillary dissection in women with invasive breast cancer and sentinel node metastasis: is the extent of axillary surgery critical to the cure of breast cancer? (2012) (0)
- Male Breast Lesions (2017) (0)
- Abstract/Case Study Review Committee for the College of American Pathologists 2017 Annual Meeting (CAP17). (2017) (0)
- Spindle Cell Lesions (2017) (0)
- Abstract B84: The association between germline genetic variants in the PI3K pathway and PI3K mutations in breast tumors. (2012) (0)
- Activation of phosphatidylinositol 3-kinase (PI3K) as a predictor of clinical outcome in breast cancer patients (2001) (0)
- Cancer stem cell markers are enriched in normal tissue adjacent to triple negative breast cancer and inversely correlated with DNA repair deficiency (2013) (0)
- PSEUDOSARCOMATOUS TUMORS OF THE LOWER URINARY TRACT. AUTHOR'S REPLY (1992) (0)
- P-glycoprotein expression and response to chemotherapy in advanced breast cancer: An immunocytochemical comparative analysis of pretreatment cytology and posttreatment histology materials (1996) (0)
- Abstract P5-08-04: Bioscore: A novel staging system for breast cancer patients receiving neoadjuvant chemotherapy (2016) (0)
- Breast cancer, bone metastasis, non-bone metastasis, copy number imbalances, molecular inversion probe array (2013) (0)
- PTEN Key to Herceptin Response in Her2-Positive Breast Cancer (2004) (0)
- Predictors of recurrence among patients with breast cancer who achieved a pathologic complete response (pCR) after neoadjuvant systemic chemotherapy. (2011) (0)
- Atypical plant homeodomain of UBR7 functions as an H2BK120Ub ligase and breast tumor suppressor (2019) (0)
- Oncogenic lncRNA downregulates cancer cell antigen presentation and intrinsic tumor suppression (2019) (0)
- 1–17 Patterns of Chromosomal Alterations in Breast Ductal Carcinoma In Situ (2005) (0)
- Special Histologic Types of Breast Cancer: Mucinous, Secretory, Micropapillary, Neuroendocrine, Cystic Hypersecretory, Glycogen-Rich Clear Cell, and Carcinoma with Osteoclast-Like Giant Cells (2016) (0)
- HER2 Assessment by MIP Microarray in a Breast Cancer Patient with Equivocal HER2 Status (2016) (0)
- Therapeutics , Targets , and Chemical Biology De fi nition of PKC-a , CDK 6 , and MET as Therapeutic Targets in Triple-Negative Breast Cancer (2014) (0)
- Prognostic value of single nucleotide polymorphisms (SNPs) of candidate genes associated with inflammation in early-stage breast cancer. (2011) (0)
- Biology of Human Tumors In fl uence of Biospecimen Variables on Proteomic Biomarkers in Breast Cancer (2014) (0)
- Abstract 323: Combined inhibition of STAT-3 & DNA repair in palbociclib resistant breast cancer (2019) (0)
- Abstract B44: The relationship between physical activity, obesity, and breast cancer characteristics among Mexican American and African American women (2009) (0)
- HeparinfHeparan Sulfate Interacting Protein Expression and Functions in Human Breast Cancer Cells and Normal Breast Epithelia 1 (2006) (0)
- Proteomic prediction in hormone receptor-positive breast cancer. (2006) (0)
- Hierarchical clustering of downregulated genes in invasive ductal carcinoma (IDC) ( 0 (2011) (0)
- Abstract P4-06-03: Assessment of intratumoral heterogeneity in early stage estrogen receptor (ER) positive breast cancer (2020) (0)
- Chromogenic In Situ Hybridization for a64 Integrin in Breast Cancer (2004) (0)
- Noninvasive breast cancer (2018) (0)
- Anatomic Pathology / DIAGNOSING ATYPICAL DUCTAL HYPERPLASIA BY DIRECTIONAL VACUUM-ASSISTED STEREOTACTIC BIOPSY (2003) (0)
- Abstract LB-193: Ganglioside GD2 identifies cancer stem cells and inhibition of GD2 biosynthesis by targeting GD3 synthase exerts antitumor effects (2012) (0)
- Effect of Trastuzumab on Locoregional Recurrence in HER2-Positive Breast Cancer According to ER/PR Status (2011) (0)
- Decrease in bcl-2 expression shortly after neoadjuvant chemotherapy predicts primary breast cancer response to treatment (2001) (0)
- Abstract 1186: Patient-derived breast cancer xenografts demonstrate molecular evolution in the phosphatidylinositol 3-kinase pathway upon engraftment (2014) (0)
- Cyclooxygenase-2 is frequently overexpressed in human breast cancers (2001) (0)
- Bio-Repository of Breast Tissue (2010) (0)
- Benign Sclerosing Lesions (2017) (0)
- Abstract 3772: Cyclin E as a prognostic marker and predictor of response to neoadjuvant chemotherapy and adjuvant hormonal therapy in patients with stage II-III breast cancer (2015) (0)
- Erratum to: Elafin is downregulated during breast and ovarian tumorigenesis but its residual expression predicts recurrence (2015) (0)
- Abstract PR-4: Increased odds of family history for triple negative breast cancer in Mexican American but not African American women (2009) (0)
- 98O The immunomodulatory (IM) signature enhances prediction of pathologic complete response (pCR) to neoadjuvant therapy (NAT) in triple negative breast cancers (TNBC) with moderate stromal tumour infiltrating lymphocytes (sTIL) (2020) (0)
- High-Grade Spindle Cell Lesions of the Breast: Key Pathologic and Clinical Updates. (2022) (0)
- LCIS: Is tamoxifen a rational chemoprevention choice? (2005) (0)
- The Optimal Number of Sentinel Lymph Nodes for Focused Pathologic Examination (2005) (0)
- Abstract 3271: The association between germline genetic variants in the PI3K-AKT-mTOR pathway and breast cancer disease free survival (2014) (0)
- Molecular portraits of mammographic breast density in normal breast tissue (2008) (0)
- Normal Breast and Physiological Changes (2017) (0)
- Assessing Tumor Percentage: A Possible Solution in Evaluating HER2 Copy Number (HER2CN) Data Generated by Molecular Inversion Probe (MIP) Technology on Formalin-Fixed Paraffin-Embedded (FFPE) Sections of Breast Cancer (BC) With Low Tumor Cellularity (2015) (0)
- Abstract 2607: Genetic variants in the vitamin D pathway and breast cancer disease free survival (2012) (0)
- Human Breast Cancer Gene in SYK Hypermethylation Leads to Silencing of the Updated (2001) (0)
- Abstract 907: Brain microenvironment induced PTEN loss by microRNAs promotes brain metastasis (2016) (0)
- Intraoperative evaluation of sentinel lymph nodes for breast cancer (2005) (0)
- Diabetic mastopathy : A masquerader of breast cancer : A report of two cases (1996) (0)
- Intraoperative imprint cytology examination of sentinel lymph nodes after neoadjuvant chemotherapy in breast cancer patients (2011) (0)
- Abstract 515: Single-cell transcriptomic analysis of HR+/HER2- breast cancer identifies gene signatures that predict outcomes of luminal A and B subtypes (2022) (0)
- Abstract 1105: Tumor cells of the early metastatic process show up regulation of cytokine genes involved in migration of inflammatory cells (2018) (0)
- QS295. Cyclin E Deregulation Is an Early Event in the Development of Breast Cancer (2009) (0)
- Phase II trial of AKT inhibitor MK-2206 in patients with advanced breast cancer who have tumors with PIK3CA or AKT mutations, and/or PTEN loss/PTEN mutation (2019) (0)
- Assessment of Breast Cancer With Borderline HER2 Status Using MIP Microarray (2017) (0)
- STK15/BTAK/aurora-A expression in ductal carcinoma in situ of the breast (2001) (0)
- HER2 targeted therapy and outcome in HER2-equivocal cases after 2018 ASCO/CAP HER2 guideline modification. (2019) (0)
- Long-term outcome of patients with complete eradication of cytologically proven axillary node metastases after primary chemotherapy: The University of Texas M. D. Anderson Cancer Center experience. (2004) (0)
- Phase II Clinical Trial of N-( 4-Hydroxyphenyl ) retinamide and Tamoxifen Administration before Definitive Surgery for Breast Neoplasia 1 (2002) (0)
- Feasibility of the use of primary breast epithelial cell cultures to identify genotype-specific preventive agents (2005) (0)
- Needle Localization and Excision of Lesions Poorly Visible or Invisible on Mammography Using Mammographic Landmarks (2007) (0)
- Epithelia Functions in Human Breast Cancer Cells and Normal Breast Heparin / Heparan Sulfate Interacting Protein Expression and Updated (2006) (0)
- Abstract #4721: Overcoming PTEN-loss mediated trastuzumab resistance by targeting Src family kinase (2009) (0)
This paper list is powered by the following services:
What Schools Are Affiliated With Ayşegül A. Şahin?
Ayşegül A. Şahin is affiliated with the following schools:
